| Jul 23 | Jul 22 | Jul 21 | Jul 20 | Jul 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.39K | $ -12.33K | $ -16.37K | $ -20.11K | $ -25.56K |
| Operating Income | $ -493.91K | $ -1.75M | $ -939.98K | $ -1.32M | $ -26.69M |
| EBITDA | $ -492.52K | $ -1.73M | $ -923.61K | $ -1.37M | $ -24.23M |
| Net Income | $ -387.04K | $ -1.52M | $ -1.89M | $ -1.93M | $ -23.61M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.00 | $ 32.00 | $ 296.13K | $ 43.24K | $ 317.55K |
| Total Assets | $ 12.99K | $ 206.90K | $ 480.07K | $ 85.35K | $ 520.02K |
| Total Debt | $ 791.44K | $ 801.03K | $ 761.35K | $ 430.04K | $ 177.55K |
| Net Debt | $ 791.43K | $ 801.00K | $ 465.22K | $ 386.80K | $ -140.00K |
| Total Liabilities | $ 3.32M | $ 3.32M | $ 2.96M | $ 1.86M | $ 1.27M |
| Stockholders' Equity | $ -3.31M | $ -3.11M | $ -2.48M | $ -1.78M | $ -749.41K |
| Cash Flow | |||||
| Free Cash Flow | $ -85.43K | $ -418.92K | $ -388.48K | $ -587.93K | $ -331.00K |
| Operating Cash Flow | $ -85.43K | $ -418.92K | $ -388.48K | $ -587.93K | $ -329.80K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -152.78K | $ 0.00 | $ -1.20K |
| Financing Cash Flow | $ 85.41K | $ 122.82K | $ 794.15K | $ 313.62K | $ 645.58K |
THC Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.